Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Loumpiana, Koulai"'
Autor:
Simon Smith, Woong-Yang Park, Kyoung-Mee Kim, Jeeyun Lee, Jung Yong Hong, Seung Tae Kim, Won Ki Kang, Emma Dean, Minsuk Kwon, Gahyun Kim, Ryul Kim, Kyu-Tae Kim, Peter G S Mortimer, Arsene-Bienvenu Loembé, Itziar Irurzun-Arana, Loumpiana Koulai
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 7 (2022)
Background Targeting the DNA damage repair (DDR) pathways is an attractive strategy for boosting cancer immunotherapy. Ceralasertib (AZD6738) is an oral kinase inhibitor of ataxia telangiectasia and Rad3 related protein, which is a master regulator o
Externí odkaz:
https://doaj.org/article/0fb079375db848879a747baa38eb0c19
Autor:
Julia M.W. Gee, Andrew Foxley, Pauline Finlay, Rahul Deb, Gaia Schiavon, Paul Rugman, Martin Pass, Justin P.O. Lindemann, Loumpiana Koulai, Elza C. de Bruin, Marie Cullberg, S.Y. Amy Cheung, Roberta Littleford, Petra Rauchhaus, Kieran Horgan, Ali Jahan, Samreen Ahmed, Daniel Rea, Anthony Skene, Chris Holcombe, Abigail Evans, Kwok-Leung Cheung, Robert E. Coleman, John F.R. Robertson
Purpose:The STAKT study examined short-term exposure (4.5 days) to the oral selective pan-AKT inhibitor capivasertib (AZD5363) to determine if this drug can reach its therapeutic target in sufficient concentration to significantly modulate key biomar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36ce4aaa6b32841a0165d4e23b5bbbdf
https://doi.org/10.1158/1078-0432.c.6530157.v1
https://doi.org/10.1158/1078-0432.c.6530157.v1
Autor:
Julia M.W. Gee, Andrew Foxley, Pauline Finlay, Rahul Deb, Gaia Schiavon, Paul Rugman, Martin Pass, Justin P.O. Lindemann, Loumpiana Koulai, Elza C. de Bruin, Marie Cullberg, S.Y. Amy Cheung, Roberta Littleford, Petra Rauchhaus, Kieran Horgan, Ali Jahan, Samreen Ahmed, Daniel Rea, Anthony Skene, Chris Holcombe, Abigail Evans, Kwok-Leung Cheung, Robert E. Coleman, John F.R. Robertson
Supplementary Data from Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23e07284ffe3c87c709eb8b178322f8c
https://doi.org/10.1158/1078-0432.22479243.v1
https://doi.org/10.1158/1078-0432.22479243.v1
Autor:
John F.R. Robertson, Robert E. Coleman, Kwok-Leung Cheung, Abigail Evans, Chris Holcombe, Anthony Skene, Daniel Rea, Samreen Ahmed, Ali Jahan, Kieran Horgan, Petra Rauchhaus, Roberta Littleford, S.Y. Amy Cheung, Marie Cullberg, Elza C. de Bruin, Loumpiana Koulai, Justin P.O. Lindemann, Martin Pass, Paul Rugman, Gaia Schiavon, Rahul Deb, Pauline Finlay, Andrew Foxley, Julia M.W. Gee
Publikováno v:
Clinical Cancer Research. 28:5469-5469
Autor:
Minsuk Kwon, Gahyun Kim, Ryul Kim, Kyu-Tae Kim, Seung Tae Kim, Simon Smith, Peter G S Mortimer, Jung Yong Hong, Arsene-Bienvenu Loembé, Itziar Irurzun-Arana, Loumpiana Koulai, Kyoung-Mee Kim, Won Ki Kang, Emma Dean, Woong-Yang Park, Jeeyun Lee
Publikováno v:
Journal for ImmunoTherapy of Cancer. 10:e005041
BackgroundTargeting the DNA damage repair (DDR) pathways is an attractive strategy for boosting cancer immunotherapy. Ceralasertib (AZD6738) is an oral kinase inhibitor of ataxia telangiectasia and Rad3 related protein, which is a master regulator of
Autor:
Ndumbi, Patricia, del Romero, J., Pulido, F., Velasco Arribas, M., Dronda, F., Blanco Ramos, J. Ramón, García de Olalla, P., Ocaña, I., Belda-Ibañez, J., del Amo, J., Álvarez-del Arco, D., Gennotte, Anne-Françoise, Barthélemy, C. cile La Morté, Wengenroth, Claudia, Touloumi, Giota, Ilias, Gountas, Loumpiana, Koulai, Olga, Anagnostou, Schüttfort, Gundolf, Wenganroth, Claudia, Barros, Henrique, Meireles, Paula, del Amo, Julia, Álvarez, D. bora, Monge, Susana, Ledergerber, Bruno, Staehelin, Cornelia, Prins, Maria, Bill, Janneke, Zuure, Freke, Prestileo, Tullio, Petrosillo, Nicolla, Burns, Fiona, Fakoya, Ibi, del Romero J, Jorge, Rodríguez, Carmen, Vera, Mar, Río, Isabel, Paredes, Vanessa, Sanz, Nieves, Dronda, Fernando, Arribas, María Velasco, Mateo, María Gracia, Gutiérrez, Mar, Domingo, Pere, Knobel, Hernando, Pellicer, Teresa, Fernández, Emma, del Carmen Ligero, María, Robau, Margarita, Miró, José María, Ocaña, Inmaculada, Burgos, Joaquín, Barberà, María José, Arando, Maider, Gutiérrez, F. lix, Masía, Mar, Blanco, José Ramón, Belda-Ibáñez, Josefina, García, Elisa Fernández, Espinosa, Trinidad Zafra, López-Lirola, Ana, Salavert, Miguel, Montero, Marta, Calabuig, Eva, Cuellar, Sandra, Vinciana, Pompeyo, Palacios, Reyes, García, Federico, Peña, Alejandro, Iribarren, José Antonio, Aguado, Mirian, Pulido, Federico, Portillo, Ángel, Gómez-Sirvent, José Luis
Publikováno v:
European journal of public health, 28(3), 451-457. Oxford University Press
Background In Spain, migrants are disproportionately affected by HIV and experience high rates of late diagnosis. We investigated barriers to health care access among migrants living with HIV (MLWH) in Spain. Methods Cross sectional electronic survey
Autor:
John F R, Robertson, Robert E, Coleman, Kwok-Leung, Cheung, Abigail, Evans, Chris, Holcombe, Anthony, Skene, Daniel, Rea, Samreen, Ahmed, Ali, Jahan, Kieran, Horgan, Petra, Rauchhaus, Roberta, Littleford, S Y Amy, Cheung, Marie, Cullberg, Elza C, de Bruin, Loumpiana, Koulai, Justin P O, Lindemann, Martin, Pass, Paul, Rugman, Gaia, Schiavon, Rahul, Deb, Pauline, Finlay, Andrew, Foxley, Julia M W, Gee
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 26(7)
The STAKT study examined short-term exposure (4.5 days) to the oral selective pan-AKT inhibitor capivasertib (AZD5363) to determine if this drug can reach its therapeutic target in sufficient concentration to significantly modulate key biomarkers of